Benzinga's Top Initiations

By: via Benzinga
Stifel Nicolaus initiated coverage on Celator Pharmaceuticals Inc (NASDAQ: CPXX) with a Buy rating. Celator Pharmaceuticals shares ...
Data & News supplied by www.cloudquote.io
Stock quotes supplied by Barchart
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the following
Privacy Policy and Terms and Conditions.